Komori
Other Disclosures6905COSEL CO.,LTD.Electrical Equipment and Precision Instruments

Development and Sales of the “FDA Series” Compact AC-DC Power Supplies for High Input Voltages

The FDA Series of AC-DC power supplies, which supports high input voltages and is more compact than the existing FCA Series, will be developed and commercialized in 50W, 75W, 150W and 200W models. The products are scheduled to begin launching from June 2026.

Worth reading
62In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
2
¥100 million per year (projected revenue three years after launch)
Wording
Conditional
How definitive the wording is.

Announced details

FDA SeriesFDA50FFDA75FFDA150FFDA200F
Applicable field (uses covered by this announcement)
Factory equipment and FA control equipmentMotor control equipment, including inverters and servo drivesSemiconductor manufacturing equipment and related equipmentIndustrial robots and their control equipmentOther equipment for general industrial applications
Launch dateJune 2026 onward (planned)
What the company reported numerically
Quantitative Effects

FDA75F is approximately 24% smaller than the FCA Series

FDA200F is approximately 56% smaller than the FCA Series

Award/certification name

UL

C-UL

DEMKO

CE marking (compliance with the Low Voltage Directive and RoHS Directive)

Impact on Business Performance

Revenue from the new products is expected to reach ¥200 million per year three years after launch

The company does not address Contract Value / Offering price.

Announced details
ItemDetails
Names of Products / Services CoveredFDA Series, FDA50F, FDA75F, FDA150F, FDA200F
Launch dateJune 2026 onward (planned)
Applicable areaFactory equipment and FA control equipment, Motor control equipment, including inverters and servo drives, Semiconductor manufacturing equipment and related equipment, Industrial robots and their control equipment, Other equipment for general industrial applications
Award/certification nameUL, C-UL, DEMKO, CE marking (compliance with the Low Voltage Directive and RoHS Directive)
Quantitative EffectsFDA75F is approximately 24% smaller than the FCA Series, FDA200F is approximately 56% smaller than the FCA Series
Impact on Business PerformanceRevenue from the new products is expected to reach ¥200 million per year three years after launch
Items this document does not state (12)
CounterpartyCounterparty overviewRelationship with the CompanyContract ValueOffering priceContract DateAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleUsage historySource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To address the increasing voltage of factory equipment and infrastructure devices, advances in equipment design aimed at reducing losses and improving efficiency, and demand for smaller, space-saving equipment.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Development and Sales of the “FDA Series” Compact AC-DC Power Supplies for High Input Voltages | COSEL CO.,LTD. (6905) timely disclosure | Komori